Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Escherichia coli F1Fo-ATP synthase is a complex, membrane-bound enzyme that plays a central role in energy transduction by coupling the flow of protons across the inner membrane to the synthesis of adenosine triphosphate (ATP) (UniProt Consortium, 2023). The enzyme is composed of two distinct sectors: the F1 catalytic domain, which extends into the cytoplasm, and the Fo proton-conducting domain, which is embedded within the phospholipid bilayer (Walker, 2013). In E. coli, the enzyme is reversible, allowing it to either produce ATP during oxidative phosphorylation or maintain a proton gradient through ATP hydrolysis during fermentation (Ahmad et al., 2020). Because of its vital role in maintaining cellular energy homeostasis and the proton motive force, it is a prominent target for antimicrobial research (Hong-Geller et al., 2020). While many clinical inhibitors like bedaquiline are specific to mycobacteria, the E. coli enzyme serves as the primary structural and functional model for understanding bacterial F-type ATPases. Therapeutic strategies targeting this enzyme aim to disrupt bacterial viability by depleting energy reserves or collapsing the electrochemical gradient. However, a major challenge in drug development is ensuring selectivity to avoid inhibiting the highly conserved human mitochondrial ATP synthase (PubMed, 2021).
Inhibition of the rotary catalysis mechanism by either blocking the Fo proton channel or binding to the F1 catalytic subunits, thereby preventing the coupling of proton translocation to ATP synthesis/hydrolysis.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Escherichia coli F1Fo-ATP synthase (E. coli ATP synthase).